Shattuck Labs, Inc. (STTK)
4.595
-0.06
(-1.39%)
USD |
NASDAQ |
Nov 17, 16:00
4.45
-0.14
(-3.16%)
After-Hours: 20:00
Shattuck Labs EPS Diluted (Quarterly) : -0.1376 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.1376 |
| June 30, 2026 | -0.1168 |
| March 31, 2026 | -0.1316 |
| December 31, 2025 | -0.1213 |
| September 30, 2025 | -0.1393 |
| June 30, 2025 | -0.2443 |
| March 31, 2025 | -0.2688 |
| December 31, 2024 | -0.3674 |
| September 30, 2024 | -0.328 |
| June 30, 2024 | -0.4243 |
| March 31, 2024 | -0.3659 |
| December 31, 2023 | -0.4112 |
| September 30, 2023 | -0.6484 |
| June 30, 2023 | -0.5026 |
| March 31, 2023 | -0.4883 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.5994 |
| September 30, 2022 | -0.5812 |
| June 30, 2022 | -0.6458 |
| March 31, 2022 | -0.5791 |
| December 31, 2021 | 0.1754 |
| September 30, 2021 | -0.413 |
| June 30, 2021 | -0.5631 |
| March 31, 2021 | -0.2828 |
| December 31, 2020 | -0.2876 |
| September 30, 2020 | -0.2834 |
| June 30, 2020 | -0.1487 |
| March 31, 2020 | -0.1569 |
| December 31, 2019 | -0.1765 |
| September 30, 2019 | -0.1744 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.628 |
| Protagonist Therapeutics, Inc. | 3.067 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.20M |
| Total Expenses (Quarterly) | 25.20M |
| Enterprise Value | 280.68M |
| Earnings Yield | -11.04% |
| Normalized Earnings Yield | -11.03 |